◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › PFSA

Profusa, Inc. (PFSA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-09

Profusa, Inc. (PFSA) operates in the Medical Devices industry and is headquartered in Berkeley, United States. Its market capitalization is roughly $1 million. In the fiscal year ended 2025-12-31, PFSA reported $0M in revenue and ($36M) in net income.

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.

Interactive charts & full statements →

PFSA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$0M$0M$0M
Operating Income (EBIT)($28M)($4M)($6M)($9M)
Net Income($36M)($9M)($10M)($20M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFSA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$0M$0M$0M
Operating Income (EBIT)($4M)($4M)($22M)($1M)($1M)
Net Income($4M)($9M)($22M)($8M)($3M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFSA Free Cash Flow History

PFSA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$4M$3M$2M$1M
Total Liabilities$30M$122M$112M$101M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PFSA viewer.

Other Companies in Medical Devices

← PFSAll stocksPFSI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.